Attacking Ivermectin and your readers is weird, Alex
The study that Alex Berenson is using to bludgeon his readers with was done on older people who all had comorbidities and who were in clinical severity stage 2 or 3 with Covid symptoms.
This post is in response to the attack by Alex Berenson, on those who support Ivermectin as a treatment for Covid.
All the doctors I've heard supporting Ivermectin1 have consistently said that IVM needs to be administered as early as possible, preferably even before symptoms and as prophylaxis. This study that Alex is using to bludgeon his readers with was done on older people who all had comorbidities and who already had symptoms and were in clinical severity stage 2 or 3.
The study enrolled patients with reverse transcriptase–polymerase chain reaction (RT-PCR) test–confirmed or antigen test–confirmed COVID-19 who were 50 years or older with at least 1 comorbidity and presented with mild to moderate illness (Malaysian COVID-19 clinical severity stage 2 or 3; WHO clinical progression scale 2-4)20,21 within 7 days from symptom onset.
I have a hard time trusting the objectivity of medical journals anymore. Health care is no longer about making people healthy. It’s about making big pharma money. Just check out the biased language from the study:
Despite the success of COVID-19 vaccines [No studies need be cited. Just trust us. They were successful.] and the implementation of nonpharmaceutical public health measures [Yep. We thought the masking, social distancing and other totalitarian measures were awesome!], there is an enormous global need for effective therapeutics for SARS-CoV-2 infection [For reals? But me fot duh wacines was wurking]. At present, repurposed anti-inflammatory drugs (dexamethasone, tocilizumab, and sarilumab),1-3 monoclonal antibodies,4-6 and antivirals (remdesivir, molnupiravir, and nirmatrelvir/ritonavir)7-9 have demonstrated treatment benefits at different stages of COVID-19.10 [No HCQ?]
Notice that they don’t mention the effectiveness of Hydroxichloroquin? 2 Or Quercitin, D3, Vitamin C, etc. They only talk about the more expensive drugs that pharmaceutical companies can and do make money on. The fact that remdesivir, which costs $3,112 per patient3, is still being defended in this study over HCQ is proof enough for me4 that the Big Pharma bias played a role in the findings.
My guess is that the authors could not have gotten this study published if they had included HCQ (or the hundreds of studies that show Ivermectin effective in the earliest stages) in this list. It’s just another hit piece paid for or at the very least, steered by big pharma interests.
Big Pharma: Generic drugs can’t possibly be effective! They don’t…sniff…make us any money! Anyone who prescribes them off label had better be ready to retire!
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Alliance-I-MASKplus-Protocol-ENGLISH.pdf (This protocol shows that IVM is being recommended as prophylaxis and in early treatment.)